TO : ALL CONCERNED

SUBJ. : DFA ADMINISTRATIVE ORDER 2010 0008,

ON NO APPROVED THERAPEUTIC CLAIM


ADVISORY

This Advisory is being issued in response to queries on the effect of the Preliminary Injunction issued by
the Regional Trial Court, Branch 30, Manila, in SP.C.A. NO. 10-123429, last May 28, 2010, against the
implementation of FDA Administrative Order 2010 0008 requiring that all advertisements and labels of
food supplements should contain the following:

MAHALAGANG PAALALA: ANG (NAME OF PRODUCT) AY HINDI GAMOT AT
HINDI DAPAT GAMITING PANGGAMOT SA ANUMANG URI NG SAKIT

Until an Order is issued by the Court lifting the same, the applicable notice on advertising materials and
labels is the one required under BFAD Memorandum Circular No. 25 s. 1992 and No. 02 s. 1999 which is:

NO APPROVED THERAPEUTIC CLAIMS

Subject to other requirements under the ASC Rules and Regulations and ASC Standards of Advertising,
materials bearing the notice No Approved Therapeutic Claims for covered products shall be accepted
for screening.

We are making representations with the FDA to clarify the matter of compliance of advertising
materials containing the notice: Ang (name of product) ay hindi gamot at hindi dapat gamiting
panggamot sa anumang uri ng sakit, as the same were made in good faith. In the meantime,
materials containing the said revised notice shall NOT be required to be pulled out unless the Advertiser
voluntarily revises/pulls out the same.

FOR YOUR GUIDANCE.


(sgd) A.G. ALCANTARA, JR.
ASC General Manager

WITH ASSISTANCE OF:


ATTY. REJIE JULARBAL
ASC Counsel
ASC Circular No. 2010-008